{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:04:30Z","timestamp":1773234270326,"version":"3.50.1"},"reference-count":7,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.clml.2016.04.013","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T16:13:24Z","timestamp":1462464804000},"page":"e109-e112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Treatment With Doxycycline for Severe Bortezomib-Associated Blepharitis"],"prefix":"10.1016","volume":"16","author":[{"given":"Marie-Charlotte","family":"Veys","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Delforge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse","family":"Mombaerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2016.04.013_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/ICU.0000000000000164","article-title":"Medical management of blepharitis","volume":"26","author":"Duncan","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.clml.2016.04.013_bib2","first-page":"CD005556","article-title":"Interventions for chronic blepharitis","volume":"5","author":"Lindsley","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clml.2016.04.013_bib3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/dc.20092","article-title":"Cytopathology of chalazia","volume":"31","author":"Dhaliwal","year":"2004","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.clml.2016.04.013_bib4","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.4081\/hr.2015.5729","article-title":"Chalazia development in multiple myeloma: a new complication associated with bortezomib therapy","volume":"7","author":"Yun","year":"2015","journal-title":"Hematol Rep"},{"key":"10.1016\/j.clml.2016.04.013_bib5","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ophtha.2014.04.021","article-title":"Chalazia associated with bortezomib therapy for multiple myeloma","volume":"121","author":"Grob","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clml.2016.04.013_bib6","first-page":"1","article-title":"Association between bortezomib therapy and eyelid chalazia","volume":"15","author":"Fraunfelder","year":"2015","journal-title":"JAMA Opthalmol"},{"key":"10.1016\/j.clml.2016.04.013_bib7","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","article-title":"Safety of doxycycline and minocycline: a systematic review","volume":"9","author":"Smith","year":"2005","journal-title":"Clin Ther"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265016300568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265016300568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:28:04Z","timestamp":1761870484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265016300568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":7,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S2152265016300568"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2016.04.013","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment With Doxycycline for Severe Bortezomib-Associated Blepharitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2016.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}